Literature DB >> 15082575

Fistulising Crohn's disease: MMPs gone awry.

D Schuppan1, T Freitag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15082575      PMCID： PMC1774058          DOI： 10.1136/gut.2003.034207

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  28 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

Review 2.  Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

Authors:  Andrew H Baker; Dylan R Edwards; Gillian Murphy
Journal:  J Cell Sci       Date:  2002-10-01       Impact factor: 5.285

3.  Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype.

Authors:  S L Pender; M T Salmela; G Monteleone; D Schnapp; C McKenzie; J Spencer; S Fong; U Saarialho-Kere; T T MacDonald
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Fibrogenesis and fibrolysis in collagenous colitis. Patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1 gene expression.

Authors:  U Günther; D Schuppan; M Bauer; H Matthes; A Stallmach; A Schmitt-Gräff; E O Riecken; H Herbst
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

5.  The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts.

Authors:  C C Chen; N Chen; L F Lau
Journal:  J Biol Chem       Date:  2000-12-18       Impact factor: 5.157

6.  Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

Authors:  R B Heuschkel; T T MacDonald; G Monteleone; M Bajaj-Elliott; J A Smith; S L Pender
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

7.  Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.

Authors:  B von Lampe; B Barthel; S E Coupland; E O Riecken; S Rosewicz
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

8.  Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors.

Authors:  Z Liu; J Klominek
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

9.  Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.

Authors:  M T Salmela; T T MacDonald; D Black; B Irvine; T Zhuma; U Saarialho-Kere; S L F Pender
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

10.  Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.

Authors:  Janelle L Lauer-Fields; Thilaka Sritharan; M Sharon Stack; Hideaki Nagase; Gregg B Fields
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157
View more
  2 in total

1.  Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.

Authors:  W T van Haaften; J H Mortensen; M A Karsdal; A C Bay-Jensen; G Dijkstra; P Olinga
Journal:  Aliment Pharmacol Ther       Date:  2017-05-08       Impact factor: 8.171

Review 2.  Metalloproteinases in Inflammatory Bowel Diseases.

Authors:  Martin Marônek; Irene Marafini; Roman Gardlík; René Link; Edoardo Troncone; Giovanni Monteleone
Journal:  J Inflamm Res       Date:  2021-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.